1. Oğuz, Ali Kemal, Oygür, Çağdaş Şahap, Taşır, Seda, Özdağ, Hilal, Akar, Mehmet Nejat. . Behçet syndrome: The disturbed balance between anti- (CLEC12A, CLC) and proinflammatory (IFI27) gene expressions. In Immunity, inflammation and disease, 11, e836. doi:10.1002/iid3.836. https://pubmed.ncbi.nlm.nih.gov/37102643/
2. Morsink, Linde M, Walter, Roland B, Ossenkoppele, Gert J. 2018. Prognostic and therapeutic role of CLEC12A in acute myeloid leukemia. In Blood reviews, 34, 26-33. doi:10.1016/j.blre.2018.10.003. https://pubmed.ncbi.nlm.nih.gov/30401586/
3. Chiaro, Tyson R, Bauer, Kaylyn M, Ost, Kyla S, Zac Stephens, W, Round, June L. 2023. Clec12a tempers inflammation while restricting expansion of a colitogenic commensal. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.03.16.532997. https://pubmed.ncbi.nlm.nih.gov/36993296/
4. Michou, Laëtitia, Cornélis, François, Levesque, Jean-Michel, Petit-Teixeira, Elisabeth, Fernandes, Maria J G. 2012. A genetic association study of the CLEC12A gene in rheumatoid arthritis. In Joint bone spine, 79, 451-6. doi:10.1016/j.jbspin.2011.12.012. https://pubmed.ncbi.nlm.nih.gov/22341585/
5. Li, Qiaoqiao, Liang, Chunyan, Xu, Xintong, Xing, Haizhou, Yu, Jifeng. 2022. CLEC12A plays an important role in immunomodulatory function and prognostic significance of patients with acute myeloid leukemia. In Leukemia & lymphoma, 63, 2136-2148. doi:10.1080/10428194.2022.2064986. https://pubmed.ncbi.nlm.nih.gov/35481814/
6. Chiaro, Tyson R, Greenewood, Morgan, Bauer, Kaylyn M, Zac Stephens, W, Round, June L. . Clec12a controls colitis by tempering inflammation and restricting expansion of specific commensals. In Cell host & microbe, 33, 89-103.e7. doi:10.1016/j.chom.2024.12.009. https://pubmed.ncbi.nlm.nih.gov/39788099/
智鼠故事 
